Lung Cancer

Pathologists and laboratory professionals are key members of the multidisciplinary team involved in the diagnosis, testing, and management of patients with lung cancer, including advanced non-small cell lung cancer (NSCLC). While the evolution of targeted therapies has significantly improved outcomes and quality of life in patients with advanced NSCLC, it can be difficult to keep up with recent advances in this field. ASCP is committed to developing education to help you increase your awareness of current and emerging treatment options for patients with advanced NSCLC, develop and apply effective testing algorithms for patients with advanced NSCLC, and guide medical oncologists and other multidisciplinary colleagues on their use to ensure appropriate treatment selection.

Educational Activities
Activities

ASCP Project ECHO® Videoconference Series

This series will delve deeper into the concepts presented in the online tumor board simulation to provide pathologists and laboratory professionals with knowledge related to best practices in advanced NSCLC diagnosis, testing, and management and guidance on real-life challenges they may face.

The videoconference series will be CME/CMLE-accredited, consisting of one-hour sessions utilizing the Project ECHO® approach. This approach features virtual, synchronous web conferences utilizing a proven model established by the University of New Mexico in 2007 that leverages technology to partner learners with specialty mentors through a continuous learning videoconferencing platform. The ECHO model leverages technology to provide access to scarce resources, help participants master complex topics through case-based learning, facilitate peer-to-peer sharing of best practices to improve knowledge and outcomes, reduce peer isolation, and foster professional development.

Each ECHO session will consist of a 20-minute didactic presentation from a subject matter expert on a topic related to best practices in advanced NSCLC diagnosis, testing, and management. In the remaining 40 minutes, two participants will present and share real-world cases and challenges from their institutions and seek feedback from participants and subject matter experts.

Upcoming Events

Find information about videoconferences in this series on advanced NSCLC below.

Videoconference 4: Advances in Targeted Therapies for Advanced NSCLC

Date Originally Broadcast: Thursday, October 7, 2021

Credit: 1 hour CME/CMLE

Faculty:
Christian Kunder, MD
Stanford Hospital and Clinics
Surgical Pathology

Fei Dong, MD
Brigham and Women's Hospital Dept. of Pathology

M Zehra Z Ordulu Sahin, MD
University of Florida, College of Medicine
Department of Pathology, Immunology, and Laboratory Medicine

Use the buttons below to take the course online for CME/CMLE credit or view the recording on YouTube (no credit).

Register for Online Course

View on YouTube

Need to claim credit for attending the live event? Click here. If you did not attend, you can receive credit by taking the online course accessible via the Register for Online Course button.

Videoconference 3: Overcoming Challenges to Advanced NSCLC Molecular Testing

Originally Broadcast: Thursday, August 19, 2021

Credit: 1 hour CME/CMLE

Faculty: Fei Dong, MD, Associate Program Director, Anatomic Pathology, Brigham and Women’s Hospital

Use the buttons below to take the course online for CME/CMLE credit or view the recording on YouTube (no credit).

Register for Online Course View on YouTube

Videoconference 2: Best Practices in Advanced NSCLC Specimen Management

Originally Broadcast: Thursday, June 24, 2021

Credit: 1 hour CME/CMLE

If you were not able to attend the live event, you can use the buttons below to take the course online for CME/CMLE credit or view the recording without credit.

Register for Online Course View on YouTube

Videoconference 1: Optimizing Test Ordering for Patients with Advanced NSCLC

Originally Broadcast: Thursday, April 22, 2021

Credit: 1 hour CME/CMLE

If you were not able to attend the live event, you can use the buttons below to take the course online for CME/CMLE credit or view the recording without credit.

Register for Online Course View on YouTube

Would you like to present in future ECHOs?
ASCP is recruiting 2 individuals to share challenges and/or best practices during each upcoming videoconference in this series. If you are interested, we want to hear from you! Please contact grants@ascp.org to learn more.

Watch for additional sessions in the series:

Videoconference 5 – TBA, December 2021

Funded by independent educational grants from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, and Pfizer, Inc.

Advanced Non-Small Cell Lung Cancer Molecular Tumor Board Simulation

This CME/CMLE-accredited 1-hour molecular tumor board simulation is designed to help pathologists, laboratory professionals, and other members of the interdisciplinary cancer care team gain deeper scientific knowledge and skills in diagnosing, testing, and managing advanced non-small cell lung cancer (NSCLC). Throughout the highly interactive molecular tumor board simulation, a multidisciplinary faculty panel will discuss multiple patient cases involving advanced NSCLC, and you will answer questions designed to help you carefully consider the nuances of each case, building your knowledge and skills related to the detection and optimal management of advanced NSCLC.

Register

The activity offers 1.0 CME/CMLE credit.

Register Review Case 1 (YouTube) Review Case 2 (YouTube)

Funded by independent educational grants from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, and Pfizer, Inc.

Optimizing Advanced NSCLC Biomarker Testing, Treatment and Management

While the evolution of targeted therapies has significantly improved outcomes and quality of life in patients with advanced NSCLC, it poses challenges for interprofessional members of the cancer care team. ASCP and the Association of Community Cancer Centers (ACCC) offered a half-day, interactive, CME/CMLE-accredited virtual (live) summit to help members of the cancer care team enhance their coordination of patient care and gain deeper scientific knowledge, skills, and competence in biomarker testing practices, treatment selection, and management of adverse events in patients with advanced NSCLC.

Each highly interactive session in the virtual summit will be presented by an interprofessional faculty team, feature rich scenarios and patient cases involving advanced NSCLC, and introduce the patient perspective to address the following topics:

  • Best practices in care coordination and communication to order appropriate, evidence-based biomarker testing for patients with advanced NSCLC
  • Tips and techniques for optimizing specimen/tissue adequacy for advanced NSCLC biomarker testing
  • Selection process for treatment options for ALK-positive advanced NSCLC patients
  • Managing adverse events associated with ALK inhibitors in first- and second-line treatment settings
  • Overcoming systems-level barriers to optimize advanced NSCLC biomarker testing practices
  • Use of multi-panel NGS pathology reports to guide treatment decision-making
  • NCCN testing guidelines related to ALK and ROS1 oncogene drivers

This virtual summit is being offered on-demand, free of charge.

Optimizing Advanced NSCLC Biomarker Testing, Treatment and Management

A free on-demand virtual summit for interprofessional cancer care teams

Originally broadcast May 21, 2021

Up to 4.5 CME/CMLE Credits

Session 1: You’ll learn what factors influence testing selection for patients with advanced NSCLC.

Speakers will discuss what factors influence the selection of particular testing methods, how much tissue is needed for certain types of tests, and the importance of interprofessional collaboration during the testing selection process.

Session 2: You’ll get clarity on biomarker testing methodology and recommendations.

Speakers will discuss the advantages and limitations of using different testing techniques, guidelines, and key discussions between interprofessional team members to optimize biomarker testing and patient care.

Session 3: You’ll gain insight on advanced NSCLC treatment opportunities and optimizing patient care.

Speakers will discuss available guideline-based treatment options, treatment resistance, and potential barriers towards optimizing patient care.

If you were not able to attend the live event, you can use the buttons below to take the course online for CME/CMLE credit or view the recordings on YouTube without credit.

Register for Online Course

View Session 1 (YouTube)

View Session 2 (YouTube)

View Session 3 (YouTube)

View Handouts

Supported by an independent educational grant from Pfizer, Inc.